Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in …

NL Albert, M Weller, B Suchorska, N Galldiks… - Neuro …, 2016 - academic.oup.com
This guideline provides recommendations for the use of PET imaging in gliomas. The review
examines established clinical benefit in glioma patients of PET using glucose (18F-FDG) …

Imaging intratumor heterogeneity: role in therapy response, resistance, and clinical outcome

JPB O'Connor, CJ Rose, JC Waterton… - Clinical Cancer …, 2015 - AACR
Tumors exhibit genomic and phenotypic heterogeneity, which has prognostic significance
and may influence response to therapy. Imaging can quantify the spatial variation in …

Guidelines on management of low‐grade gliomas: report of an EFNS–EANO* Task Force

R Soffietti, BG Baumert, L Bello… - European journal of …, 2010 - Wiley Online Library
Background: Diffuse infiltrative low‐grade gliomas of the cerebral hemispheres in the adult
are a group of tumors with distinct clinical, histological and molecular characteristics, and …

O-(2-[18F]fluoroethyl)-l-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas

D Pauleit, F Floeth, K Hamacher, MJ Riemenschneider… - Brain, 2005 - academic.oup.com
MRI is commonly used to determine the location and extent of cerebral gliomas. We
investigated whether the diagnostic accuracy of MRI could be improved by the additional …

[HTML][HTML] FET PET radiomics for differentiating pseudoprogression from early tumor progression in glioma patients post-chemoradiation

P Lohmann, MA Elahmadawy, R Gutsche, JM Werner… - Cancers, 2020 - mdpi.com
Simple Summary Following chemoradiation with alkylating agents in glioma patients,
structural magnetic resonance imaging (MRI) may suggest tumor progression which …

Current status of PET imaging in neuro-oncology

N Galldiks, P Lohmann, NL Albert… - Neuro-Oncology …, 2019 - academic.oup.com
Over the past decades, a variety of PET tracers have been used for the evaluation of patients
with brain tumors. For clinical routine, the most important clinical indications for PET imaging …

Value of 11C-methionine PET in imaging brain tumours and metastases

AWJM Glaudemans, RH Enting… - European journal of …, 2013 - Springer
Abstract 11 C-methionine (MET) is the most popular amino acid tracer used in PET imaging
of brain tumours. Because of its characteristics, MET PET provides a high detection rate of …

Molecular imaging of gliomas with PET: opportunities and limitations

C la Fougere, B Suchorska, P Bartenstein… - Neuro …, 2011 - academic.oup.com
Neuroimaging enables the noninvasive evaluation of glioma and is considered to be one of
the key factors for individualized therapy and patient management, since accurate diagnosis …

Tumor cell metabolism imaging

C Plathow, WA Weber - Journal of Nuclear Medicine, 2008 - Soc Nuclear Med
Molecular imaging of tumor metabolism has gained considerable interest, since preclinical
studies have indicated a close relationship between the activation of various oncogenes and …

An interindividual comparison of O-(2-[18F] Fluoroethyl)-L-Tyrosine (FET)–and L-[Methyl-11C] methionine (MET)–PET in patients with brain gliomas and metastases

AL Grosu, ST Astner, E Riedel, C Nieder… - International Journal of …, 2011 - Elsevier
PURPOSE: L-[methyl-11C] methionine (MET)–positron emission tomography (PET) has a
high sensitivity and specificity for imaging of gliomas and metastatic brain tumors. The short …